Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samantha K McCarty

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Endocrine-Related Cancer|September 7, 2010
Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasionSamantha K McCarty, Motoyasu Saji, Xiaoli Zhang, et al.
Endocrine-Related Cancer|September 18, 2014
BRAF activates and physically interacts with PAK to regulate cell motilitySamantha K McCarty, Motoyasu Saji, Xiaoli Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|May 28, 2013
Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migrationYihui Ma, Samantha K McCarty, Naval P Kapuriya, et al.
Endocrine-Related Cancer|November 24, 2011
Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitroYoon Woo Koh, Manisha H Shah, Kitty Agarwal, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Endocrine-Related Cancer|September 7, 2010
Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasionSamantha K McCarty, Motoyasu Saji, Xiaoli Zhang, et al.
Endocrine-Related Cancer|September 18, 2014
BRAF activates and physically interacts with PAK to regulate cell motilitySamantha K McCarty, Motoyasu Saji, Xiaoli Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|May 28, 2013
Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migrationYihui Ma, Samantha K McCarty, Naval P Kapuriya, et al.
Endocrine-Related Cancer|November 24, 2011
Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitroYoon Woo Koh, Manisha H Shah, Kitty Agarwal, et al.
Pageof 1